Glivec Film Coated Tablet 400mg Singapoo - Kiingereza - HSA (Health Sciences Authority)

glivec film coated tablet 400mg

novartis (singapore) pte ltd - imatinib mesylate eqv imatinib base - tablet, film coated - 478.00 mg eqv. 400mg imatinib base - imatinib mesylate eqv imatinib base 400 mg

ATROSAN DEVIL'S CLAW Film Coated Tablet Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

atrosan devil's claw film coated tablet

bioforce (uk) ltd - devil's claw extract (as dry root) - film coated tablet - 480 milligram

POSACONAZOLE SANDOZ posaconazole 100 mg modified release tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

posaconazole sandoz posaconazole 100 mg modified release tablet blister pack

sandoz pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose acetate succinate; microcrystalline cellulose; hyprolose; croscarmellose sodium; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole sandoz (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older:,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole sandoz is also indicated for the prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

POSACONAZOLE ARX posaconazole 100 mg modified release tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

posaconazole arx posaconazole 100 mg modified release tablet blister pack

dr reddys laboratories australia pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: hyprolose; triacetin; titanium dioxide; microcrystalline cellulose; hypromellose acetate succinate; macrogol 400; croscarmellose sodium; purified talc; iron oxide red; magnesium stearate; silicon dioxide; hypromellose - posaconazole arx (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ,? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. ,posaconazole arx is also indicated for the: ,? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

POSACONAZOLE DR.REDDY'S posaconazole 100 mg modified release tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

posaconazole dr.reddy's posaconazole 100 mg modified release tablet blister pack

dr reddys laboratories australia pty ltd - posaconazole, quantity: 100 mg - tablet, modified release - excipient ingredients: croscarmellose sodium; macrogol 400; hypromellose acetate succinate; silicon dioxide; triacetin; purified talc; hyprolose; iron oxide red; magnesium stearate; titanium dioxide; microcrystalline cellulose; hypromellose - posaconazole dr.reddy's (posaconazole) is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: ,? invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. ,? fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy. ,posaconazole dr.reddy's is also indicated for the: ,? prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

LIVALO FILM-COATED TABLETS 2MG Singapoo - Kiingereza - HSA (Health Sciences Authority)

livalo film-coated tablets 2mg

dksh singapore pte. ltd. - pitavastatin calcium hydrate 2.2mg eqv pitavastatin calcium - tablet, film coated - pitavastatin calcium hydrate 2.2mg eqv pitavastatin calcium 2.0mg

LIVALO FILM-COATED TABLETS 4MG Singapoo - Kiingereza - HSA (Health Sciences Authority)

livalo film-coated tablets 4mg

dksh singapore pte. ltd. - pitavastatin calcium hydrate 4.4mg eqv pitavastatin calcium - tablet, film coated - pitavastatin calcium hydrate 4.4mg eqv pitavastatin calcium 4.00mg

SKUDEXA FILM-COATED TABLET 75 MG25 MG Singapoo - Kiingereza - HSA (Health Sciences Authority)

skudexa film-coated tablet 75 mg25 mg

a. menarini singapore pte. ltd. - dexketoprofen trometamol 36.90 mg eqv. to dexketoprofen; tramadol hydrochloride - tablet, film coated - dexketoprofen trometamol 36.90 mg eqv. to dexketoprofen 25 mg; tramadol hydrochloride 75 mg

AUBAGIO FILM-COATED TABLETS 14mg Singapoo - Kiingereza - HSA (Health Sciences Authority)

aubagio film-coated tablets 14mg

sanofi-aventis singapore pte. ltd. - teriflunomide - tablet, film coated - teriflunomide 14.0mg

CHOLIB FILM-COATED TABLET 145MG20MG Singapoo - Kiingereza - HSA (Health Sciences Authority)

cholib film-coated tablet 145mg20mg

abbott laboratories (singapore ) private limited - fenofibrate; simvastatin - tablet, film coated - fenofibrate 145.0mg; simvastatin 20.0mg